Proton Radiation for Chordomas and Chondrosarcomas
Proton Radiation For Chordomas and Chondrosarcomas
Sponsor: Abramson Cancer Center at Penn Medicine
Listed as NCT01449149, this NA trial focuses on Chondrosarcomas and Chordomas and remains completed. Sponsored by Abramson Cancer Center at Penn Medicine, it has been updated 15 times since 2010, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Aug 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jul 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 10 earlier versions
-
Apr 2023 — Jul 2023 [monthly]
Active Not Recruiting NA
-
Jul 2022 — Apr 2023 [monthly]
Active Not Recruiting NA
-
May 2021 — Jul 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2019 — May 2020 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting · Phase: PHASE1_PHASE2 → NA
-
Jun 2018 — May 2019 [monthly]
Unknown Status PHASE1_PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Feb 2017 — Feb 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
For direct contact, visit the study record on ClinicalTrials.gov .